Bos, Maxime M.
Goulding, Neil J.
Lee, Matthew A.
Hofman, Amy
Bot, Mariska
Pool, René
Vijfhuizen, Lisanne S.
Zhang, Xiang
Li, Chihua
Mustafa, Rima
Neville, Matt J.
Li-Gao, Ruifang
Trompet, Stella
Beekman, Marian
Biermasz, Nienke R.
Boomsma, Dorret I.
de Boer, Irene
Christodoulides, Constantinos
Dehghan, Abbas
van Dijk, Ko Willems
Ford, Ian
Ghanbari, Mohsen
Heijmans, Bastiaan T.
Ikram, M. Arfan
Jukema, J. Wouter
Mook-Kanamori, Dennis O.
Karpe, Fredrik
Luik, Annemarie I.
Lumey, L. H.
van den Maagdenberg, Arn M. J. M.
Mooijaart, Simon P.
de Mutsert, Renée
Penninx, Brenda W. J. H.
Rensen, Patrick C. N.
Richmond, Rebecca C.
Rosendaal, Frits R.
Sattar, Naveed
Schoevers, Robert A.
Slagboom, P. Eline
Terwindt, Gisela M.
Thesing, Carisha S.
Wade, Kaitlin H.
Wijsman, Carolien A.
Willemsen, Gonneke
Zwinderman, Aeilko H.
van Heemst, Diana
Noordam, Raymond http://orcid.org/0000-0001-7801-809X
Lawlor, Deborah A. http://orcid.org/0000-0002-6793-2262
Funding for this research was provided by:
European Research Council (DevelopObese; 669545)
British Heart Foundation (AA/18/7/34219, 17/0005700)
Article History
Received: 6 October 2020
Accepted: 11 February 2021
First Online: 18 March 2021
Ethics approval and consent to participate
: Each participating study obtained written informed consent from all participants and received approval from the appropriate local institutional review boards.
: Not applicable.
: DOMK is a part-time research consultant at Metabolon, Inc. DAL has received research support from national and international government and charitable funders, as well as Roche Diagnostics and Medtronic for research unrelated to that presented here. DAL is an associate editor for BMC Medicine. All others declare no conflicts of interest.